The stock of Exact Sciences Corp (NASDAQ:EXAS) last traded at $53.23, down -2.72% from the previous session.
EXAS stock price is now -20.52% away from the 50-day moving average and -9.50% away from the 200-day moving average. The market capitalization of the company currently stands at $9.85B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $75, Wells Fargo recently initiated with Overweight rating for Exact Sciences Corp (NASDAQ: EXAS). On June 27, 2024, Scotiabank recently initiated its ‘Sector Outperform’ rating on the stock quoting a target price of $70, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Baranick Brian, EVP, GM, Precision Oncology sold 929 shares of the company’s stock on Oct 08 ’24. The stock was sold for $65,030 at an average price of $70.00. Upon completion of the transaction, the EVP, GM, Precision Oncology now directly owns 12,758 shares in the company, valued at $0.68 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 08 ’24, Officer Baranick Brian bought 929 shares of the business’s stock. A total of $65,030 was incurred on buying the stock at an average price of $70.00. A total of 1.51% of the company’s stock is owned by insiders.
During the past 12 months, Exact Sciences Corp has had a low of $40.62 and a high of $79.62. As of last week, the company has a debt-to-equity ratio of 0.87, a current ratio of 2.12, and a quick ratio of 1.93. The fifty day moving average price for EXAS is $67.129 and a two-hundred day moving average price translates $58.87055 for the stock.
The latest earnings results from Exact Sciences Corp (NASDAQ: EXAS) was released for 2024-09-30. The net profit margin was -7.95% and return on equity was -6.76% for EXAS. The company reported revenue of $708.65 million for the quarter, compared to $628.34 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 12.78 percent.
